Response to Comment on Dawed et al. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673-2682

Adem Y. Dawed; Sook Wah Yee; Kaixin Zhou; Nienke van Leeuwen; Yanfei Zhang; Moneeza K. Siddiqui; Amy Etheridge; Federico Innocenti; Fei Xu; Josephine H. Li; Joline W. Beulens; Amber A. van der Heijden; Roderick C. Slieker; Yu-Chuan Chang; Josep M. Mercader; Varinderpal Kaur; John S. Witte; Ming Ta Michael Lee; Yoichiro Kamatani; Yukihide Momozawa; Michiaki Kubo; Colin N. A. Palmer; Jose C. Florez; Monique M. Hedderson; Leen M. 't Hart; Kathleen M. Giacomini; Ewan R. Pearson; The DIRECT consortium

doi:10.2337/dci21-0066

Response to Comment on Dawed et al. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673-2682

Adem Y. Dawed
, Sook Wah Yee
, Kaixin Zhou
, Nienke van Leeuwen
, Yanfei Zhang
, Moneeza K. Siddiqui
, Amy Etheridge
, Federico Innocenti
, Fei Xu
, Josephine H. Li
, Joline W. Beulens
, Amber A. van der Heijden
, Roderick C. Slieker
, Yu-Chuan Chang
, Josep M. Mercader
, Varinderpal Kaur
, John S. Witte
, Ming Ta Michael Lee
, Yoichiro Kamatani
, Yukihide Momozawa

Michiaki Kubo, Colin N. A. Palmer, Jose C. Florez, Monique M. Hedderson, Leen M. 't Hart, Kathleen M. Giacomini, Ewan R. Pearson (Lead / Corresponding author), , The DIRECT consortium

MED Population Health and Genomics

Research output: Contribution to journal › Letter › peer-review

95 Downloads (Pure)

Original language	English
Pages (from-to)	e82-e83
Number of pages	2
Journal	Diabetes Care
Volume	45
Issue number	4
Early online date	29 Mar 2022
DOIs	https://doi.org/10.2337/dci21-0066
Publication status	Published - Apr 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

ASJC Scopus subject areas

Advanced and Specialised Nursing
Internal Medicine
Endocrinology, Diabetes and Metabolism

Access to Document

10.2337/dci21-0066Licence: CC BY-NC

Final published versionFinal published version, 498 KBLicence: CC BY-NC

Cite this

Dawed, A. Y., Yee, S. W., Zhou, K., van Leeuwen, N., Zhang, Y., Siddiqui, M. K., Etheridge, A., Innocenti, F., Xu, F., Li, J. H., Beulens, J. W., van der Heijden, A. A., Slieker, R. C., Chang, Y.-C., Mercader, J. M., Kaur, V., Witte, J. S., Lee, M. T. M., Kamatani, Y., ... The DIRECT consortium (2022). Response to Comment on Dawed et al. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673-2682. Diabetes Care, 45(4), e82-e83. https://doi.org/10.2337/dci21-0066

@article{46770c55862943e3a7e36a87f28eb124,

title = "Response to Comment on Dawed et al. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673-2682",

author = "Dawed, \{Adem Y.\} and Yee, \{Sook Wah\} and Kaixin Zhou and \{van Leeuwen\}, Nienke and Yanfei Zhang and Siddiqui, \{Moneeza K.\} and Amy Etheridge and Federico Innocenti and Fei Xu and Li, \{Josephine H.\} and Beulens, \{Joline W.\} and \{van der Heijden\}, \{Amber A.\} and Slieker, \{Roderick C.\} and Yu-Chuan Chang and Mercader, \{Josep M.\} and Varinderpal Kaur and Witte, \{John S.\} and Lee, \{Ming Ta Michael\} and Yoichiro Kamatani and Yukihide Momozawa and Michiaki Kubo and Palmer, \{Colin N. A.\} and Florez, \{Jose C.\} and Hedderson, \{Monique M.\} and \{'t Hart\}, \{Leen M.\} and Giacomini, \{Kathleen M.\} and Pearson, \{Ewan R.\} and \{The DIRECT consortium\}",

note = "Funding Information: Funding. The work leading to this publication has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115317 (DIRECT), resources of which are composed of financial contribution from the European Union{\textquoteright}s Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries (EFPIA) companies{\textquoteright} in-kind contribution. Funding was in part from the National Institutes of Health (NIH), R01-GM117163, to J.C.F., M.M.H., and K.M.G. E.R.P. holds a Wellcome New Investigator Award (102820/Z/13/Z). Funding for the Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH) was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, R01-DK088214. J.H.L. is supported by NIDDK, NIH, T32-DK007028. J.C.F. is supported by NIDDK, NIH, K24-DK110550. The Geisinger MyCode type 2 diabetes project was supported by the Geisinger Health Plan Quality Pilot Fund (principal investigator: M.T.M.L.). Duality of Interest. E.R.P. has received honoraria for speaking from Lilly and Sanofi. J.C.F. has received honoraria for speaking at scientific conferences from Novo Nordisk and for consulting from Goldfinch Bio. No other potential conflicts of interest relevant to this article were reported.",

year = "2022",

month = apr,

doi = "10.2337/dci21-0066",

language = "English",

volume = "45",

pages = "e82--e83",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association Inc.",

number = "4",

}

Dawed, AY, Yee, SW, Zhou, K, van Leeuwen, N, Zhang, Y, Siddiqui, MK, Etheridge, A, Innocenti, F, Xu, F, Li, JH, Beulens, JW, van der Heijden, AA, Slieker, RC, Chang, Y-C, Mercader, JM, Kaur, V, Witte, JS, Lee, MTM, Kamatani, Y, Momozawa, Y, Kubo, M, Palmer, CNA, Florez, JC, Hedderson, MM, 't Hart, LM, Giacomini, KM, Pearson, ER & The DIRECT consortium 2022, 'Response to Comment on Dawed et al. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673-2682', Diabetes Care, vol. 45, no. 4, pp. e82-e83. https://doi.org/10.2337/dci21-0066

TY - JOUR

T1 - Response to Comment on Dawed et al. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673-2682

AU - Dawed, Adem Y.

AU - Yee, Sook Wah

AU - Zhou, Kaixin

AU - van Leeuwen, Nienke

AU - Zhang, Yanfei

AU - Siddiqui, Moneeza K.

AU - Etheridge, Amy

AU - Innocenti, Federico

AU - Xu, Fei

AU - Li, Josephine H.

AU - Beulens, Joline W.

AU - van der Heijden, Amber A.

AU - Slieker, Roderick C.

AU - Chang, Yu-Chuan

AU - Mercader, Josep M.

AU - Kaur, Varinderpal

AU - Witte, John S.

AU - Lee, Ming Ta Michael

AU - Kamatani, Yoichiro

AU - Momozawa, Yukihide

AU - Kubo, Michiaki

AU - Palmer, Colin N. A.

AU - Florez, Jose C.

AU - Hedderson, Monique M.

AU - 't Hart, Leen M.

AU - Giacomini, Kathleen M.

AU - Pearson, Ewan R.

AU - The DIRECT consortium

N1 - Funding Information: Funding. The work leading to this publication has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement no. 115317 (DIRECT), resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries (EFPIA) companies’ in-kind contribution. Funding was in part from the National Institutes of Health (NIH), R01-GM117163, to J.C.F., M.M.H., and K.M.G. E.R.P. holds a Wellcome New Investigator Award (102820/Z/13/Z). Funding for the Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans (SUGAR-MGH) was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, R01-DK088214. J.H.L. is supported by NIDDK, NIH, T32-DK007028. J.C.F. is supported by NIDDK, NIH, K24-DK110550. The Geisinger MyCode type 2 diabetes project was supported by the Geisinger Health Plan Quality Pilot Fund (principal investigator: M.T.M.L.). Duality of Interest. E.R.P. has received honoraria for speaking from Lilly and Sanofi. J.C.F. has received honoraria for speaking at scientific conferences from Novo Nordisk and for consulting from Goldfinch Bio. No other potential conflicts of interest relevant to this article were reported.

PY - 2022/4

Y1 - 2022/4

UR - https://www.scopus.com/pages/publications/85127303738

U2 - 10.2337/dci21-0066

DO - 10.2337/dci21-0066

M3 - Letter

C2 - 35349657

SN - 0149-5992

VL - 45

SP - e82-e83

JO - Diabetes Care

JF - Diabetes Care

IS - 4

ER -

Response to Comment on Dawed et al. Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021;44:2673-2682

UN SDGs

ASJC Scopus subject areas

Access to Document

Other files and links

Genome-wide meta-analysis identifies genetic variants associated with glycemic response to sulfonylureas

Cite this